QualiCell® Human Neuronal Stem Cells (Hippocampus) -XLC418

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C00350
Description
Human Neuronal Stem Cells (Hippocampus Derived) (Plated cells are also available). 120 Population doublings or up to 12 passages. One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice. Cells are only guaranteed with purchase of Creative Bioarray Media, Extra Cellular Matrix, Trypsin EDTA, 1X PBS, and freezing media for the appropriate cell culture, for 30 days from the date of shipment.
Species
Human
Storage and Shipping
Liquid nitrogen. Dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human hippocampal neural stem cells (NSCs) reside in the subgranular zone (SGZ) of the dentate gyrus (DG), one of the two principal neurogenic niches in the adult mammalian brain. Unlike cortical NSCs, which are primarily fetal-derived and generate glutamatergic projection neurons, hippocampal NSCs sustain lifelong neurogenesis, continuously producing new granule neurons that integrate into existing hippocampal circuits. This enduring plasticity underpins their unique advantages for both fundamental neuroscience and translational applications.

First, lifelong neurogenic capacity – hippocampal NSCs remain active throughout life, generating neurons that critically support learning, memory, and pattern separation. This property is absent in cortical NSCs, which exhibit limited postnatal neurogenesis.

Second, region-specific neuronal output – upon differentiation, hippocampal NSCs preferentially generate DG granule neurons—a restricted lineage distinct from the diverse pyramidal and interneuron subtypes produced by cortical NSCs. This specified fate makes them uniquely suited for modelling hippocampal-dependent cognitive processes and disorders.

Third, therapeutic relevance for memory-related pathologies – hippocampal NSCs are directly implicated in Alzheimer's disease, epilepsy, depression, and age-related cognitive decline. Transplantation of human hippocampal NSCs has been shown to rescue cognitive deficits and reinforce synaptic networks in preclinical models.

Fourth, human-specific relevance – unlike rodent models, human hippocampal NSCs exhibit deeper quiescence and lower baseline neurogenesis, more accurately reflecting the human condition. Single-cell studies have revealed molecular heterogeneity—quiescent, primed, and active NSC states—providing a framework for understanding age-related decline and disease vulnerability.

The Effects of Cannabidiol and Its Main Metabolites on Human Neural Stem Cells

In the present study, human neural stem cells (NSCs) were treated with cannabidiol (CBD) and its metabolites (7-OH-CBD and 7-COOH-CBD) to understand how the drug may affect fetal brain development. NSCs were also treated with delta-9 tetrahydrocannabinol (THC) for comparison purposes.

CBD, 7-OH-CBD and 7-COOH-CBD dose-dependently reduced NSC viability. CBD and 7-OH-CBD reduced NSC number at the G1 phase. A 24 h exposure did not cause significant change in NSC proliferation. At concentrations comparable to those detected in human blood, longer exposures to CBD, 7-OH-CBD and 7-COOH-CBD caused more obvious cell death. After NSCs differentiation, CBD treatment reduced GFAP and cannabinoid receptor 2 (CB2) expression. THC treatment reduced the GFAP expression, but the change in CB2 expression did not reach statistical significance. The expression of cannabinoid receptor 1 (CB1) and beta-tubulin III were not significantly altered by drug exposures. The study demonstrated that clinically relevant concentrations of CBD, 7-OH-CBD and 7-COOH-CBD affect basic physiological features of human NSCs. After NSC differentiation, the reduced expression of CB2 receptors and GFAP on differentiated cells further indicated the vulnerability of developing central nervous system to CBD and THC. These data will help to contextualize in vivo neurodevelopmental studies that may not accurately model human metabolite profiles of CBD.

NSC apoptosis detected by annexin V-PI staining and TUNEL assay.
Fig. 1. Cell death detected by Annexin V-PI staining and TUNEL assay (Latham, Leah E., et al., 2025).
Expression levels of β-tubulin III, GFAP, OMG, caspase 3, CB1 and CB2 receptors after drug exposures.
Fig. 2. Western blots of β-tubulin III, GFAP, OMG, pro-caspase 3, CB1 and CB2 receptors in differentiated cells (Latham, Leah E., et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products